후성 유전학 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년에는 CAGR 22.7%로 290억 8,000만 달러로 성장합니다. 예측 기간의 성장은 후성 제약 개발, 환경 위생의 후성, 정밀 농업의 후성, 규제 지원, 환자 의식 및 광고에 기인합니다. 예측 기간의 주요 동향은 에피트란스크립트 믹스, 싱글셀 에피유전체, 에피제네틱 편집, 에피제네틱 바이오마커, 노화·장수 연구, 마이크로바이옴-에피유전체 상호작용 등입니다.
암 및 기타 질병의 유병률 증가는 후성 유전 시장의 성장을 크게 촉진하고 있습니다. 질병 발생률이 증가함에 따라 후성 유전체 수요도 증가합니다. 예를 들어, 2024년 5월 미국을 거점으로 하는 정부기관인 국립암연구소(NCI)는 2022년에 약 2,000만명의 암 환자가 새롭게 기록되어 그 결과 이 질병과 관련하여 약 970만명이 사망했다고 보고했습니다. 예측에 따르면, 2040년까지 신규 암 이환 환자 수는 연간 2,990만명으로 증가하고, 암 관련 사망은 1,530만명에 이릅니다. 또한 미국 질병 예방관리센터(CDC)의 추계에 따르면 미국에서는 매년 약 65만 9,000명이 심장병으로 사망하고 있습니다. 암 및 기타 질병의 유병률이 증가함에 따라 유전자의 변화를 검사하고 이해할 필요가 있으며, 필연적으로 후성 유전학의 사용과 수요가 증가하고 있습니다. 그러므로 암과 기타 질병의 유병률 증가는 앞으로 몇 년동안 후성 유전 시장을 견인할 것으로 예상됩니다.
후성유전학 시장은 정밀의료에 대한 관심이 높아지고 있기 때문에 성장이 예상됩니다. 정밀의료는 보다 효과적인 질병 관리 및 치료를 위해 개인의 유전적, 환경적, 라이프스타일 정보를 기반으로 의료 접근법을 조정하는 것입니다. 후성 유전학 분야에서 정밀의료는 개인의 후성 유전 프로파일과 유전자 데이터를 활용하여 개인화된 건강 관리 전략을 수립합니다. 맞춤형 의료연합(Personalized Medicine Coalition)에 따르면 2022년 식품의약국(FDA)의 의약품 평가연구센터(Center for Drug Evaluation and Research)는 37개의 치료용 신규 분자체를 승인했으며, 그 중 34%가 개별화 의약품으로 분류되었습니다. 이와 같이 정밀의료가 중시되고 있는 것이 후성유전학 시장의 확대에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 에피제네틱스 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업의 분석
- 세계 후성 시장의 성장률 분석
- 세계의 에피제네틱스 시장 실적: 규모와 성장, 2019-2024년
- 세계의 에피제네틱스 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계의 후성 유전 총 주소 가능 시장(TAM)
제6장 시장 세분화
- 세계의 에피제네틱스 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 시약
- 효소
- 기기
- 키트
- 세계의 에피제네틱스 시장 : 기술별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- DNA 메틸화
- 히스톤 메틸화
- 히스톤 아세틸화
- 대형 비코딩 RNA
- 마이크로 RNA 수식
- 크로마틴 구조
- 세계의 에피제네틱스 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 종양학
- 대사성 질환
- 발생 생물학
- 면역학
- 심혈관 질환
- 기타 용도
- 세계의 에피제네틱스 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 학술연구기관
- 제약 및 바이오테크놀러지 기업
- 계약 연구 기관
- 기타 최종 사용자
- 세계의 후성 유전 시장 : 시약의 서브 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- DNA 메틸화 시약
- 히스톤 수식 시약
- RNA 변형 시약
- 효소
- 세계의 후성유전학 시장 : 효소의 서브세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- DNA 메틸트랜스퍼라제
- 히스톤 아세틸 트랜스퍼 라제
- 히스톤 탈아세틸화효소
- 기타 후성 유전 효소
- 세계의 에피제네틱스 시장 : 기기의 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 시퀀서
- PCR 기계
- 마이크로어레이 플랫폼
- 질량 분석계
- 세계의 에피제네틱스 시장 : 키트의 서브 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- DNA 메틸화 키트
- 크로마틴 면역침강(ChIP) 키트
- RNA-Seq 키트
- 아황산 수소염 변환 키트
제7장 지역별·국가별 분석
- 세계의 에피제네틱스 시장 :지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 에피제네틱스 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 후성 유전 시장 : 경쟁 구도
- 후성 유전 시장 : 기업 프로파일
- Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
- Merck Millipore Overview, Products and Services, Strategy and Financial Analysis
- Active Motif Overview, Products and Services, Strategy and Financial Analysis
- Abcam PLC Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Qiagen NV
- Diagenode SA
- CellCentric Ltd.
- Chroma Medicine Inc.
- Constellation Pharmaceuticals Inc.
- Domainex Ltd.
- Eisai Co. Ltd.
- Epigen Biosciences Inc.
- EpigenDx Inc.
- Epigenomics AG
- Epizyme Inc.
- Gilead Sciences Inc.
- GlaxoSmithKline plc
- Janssen Pharmaceuticals Inc.
- Locus Biosciences Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 시장의 최근 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 에피제네틱스 시장 2029년 - 가장 새로운 기회를 제공하는 국가
- 후성 유전 시장 2029년 - 가장 새로운 기회를 제공하는 부문
- 후성 유전 시장 2029년 - 성장 전략
제36장 부록
SHW
Epigenetics refers to changes in gene activity transmitted to younger cells without modifying the DNA sequence. These natural and necessary processes are vital for the functioning of many organisms, but anomalies can lead to disorders such as various types of cancer, reproductive illnesses, and cardiovascular diseases. Epigenetics plays a crucial role in the early detection of certain cancers.
The primary products employed in the epigenetics market include reagents, enzymes, instruments, and kits. Reagents are compounds or substances used for chemical analysis or epigenetic testing. Technologies utilized in epigenetics encompass DNA methylation, histone methylation, histone acetylation, large noncoding RNA, microRNA modification, and chromatin structures. Applications span oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other fields. Epigenetic tools find applications in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and various other end-user segments.
The epigenetics market research report is one of a series of new reports from The Business Research Company that provides epigenetics market statistics, including epigenetics industry global market size, regional shares, competitors with an epigenetics market share, detailed epigenetics market segments, market trends and opportunities, and any further data you may need to thrive in the epigenetics industry. This epigenetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The epigenetics market size has grown exponentially in recent years. It will grow from $10.65 billion in 2024 to $12.83 billion in 2025 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to increased research funding, rise in incidence of chronic diseases, personalized medicine, cancer research, aging population.
The epigenetics market size is expected to see exponential growth in the next few years. It will grow to $29.08 billion in 2029 at a compound annual growth rate (CAGR) of 22.7%. The growth in the forecast period can be attributed to epigenetic drug development, epigenetics in environmental health, epigenetics in precision agriculture, regulatory support, patient awareness and advocacy. Major trends in the forecast period include epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, aging and longevity research, microbiome-epigenome interactions.
The rising prevalence of cancer and other diseases is significantly propelling the growth of the epigenetics market. As the incidence of diseases increases, so does the demand for epigenetics. For example, in May 2024, the National Cancer Institute (NCI), a U.S.-based government agency, reported that nearly 20 million new cancer cases were documented in 2022, resulting in approximately 9.7 million deaths related to the disease. Projections suggest that by 2040, the annual incidence of new cancer cases will rise to 29.9 million, with cancer-related deaths reaching 15.3 million. Additionally, the Centers for Disease Control and Prevention (CDC) estimates that around 659,000 people in the United States die from heart disease each year. The increasing prevalence of cancer and other diseases necessitates testing and understanding the genetic modifications that occur, which will inevitably boost the usage and demand for epigenetics. Therefore, the growing prevalence of cancer and other diseases is expected to drive the epigenetics market in the coming years.
The epigenetics market is expected to experience growth due to the increasing focus on precision medicine. Precision medicine involves tailoring medical approaches based on an individual's genetic, environmental, and lifestyle information for more effective disease management and treatment. In the realm of epigenetics, precision medicine utilizes individual epigenetic profiles and genetic data to formulate personalized healthcare strategies. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research approved 37 new molecular entities, with 34% of therapeutic new molecular entities classified as personalized medicines, according to the Personalized Medicine Coalition. This emphasis on precision medicine is contributing to the expansion of the epigenetics market.
Leading companies in the epigenetics market are concentrating on developing technologically advanced solutions, such as DNA sequencing methods, to enhance precision medicine and improve disease understanding and treatment outcomes. DNA sequencing methods are techniques that determine the order of nucleotides in a DNA molecule, allowing for detailed genetic analysis. This information is vital for identifying genetic variations associated with diseases and advancing precision medicine. For example, in March 2023, Illumina Inc., a U.S.-based biotechnology company, introduced Illumina Complete Long Read Technology, which facilitates both long-read and short-read sequencing on a single instrument, significantly improving versatility in genomic research. By reducing DNA input requirements and streamlining the workflow, this technology simplifies the library preparation process, making it more accessible for challenging samples. It also achieves high accuracy in variant calling, providing reliable data that is essential for comprehensive genomic analysis.
Leading companies in the epigenetics market are increasingly incorporating artificial intelligence (AI)-driven analytics into their operations to gain a competitive advantage. AI-driven analytics involves utilizing artificial intelligence technologies to automatically analyze and interpret large volumes of data. For example, in July 2023, FOXO Technologies, a US-based company, introduced Bioinformatics Services aimed at revolutionizing epigenetic data analysis. These services offer a versatile platform with advanced data solutions tailored to meet the specific needs of clients in academia, healthcare, and pharmaceutical research. FOXO's innovative suite of bioinformatic tools aims to enhance the speed and accuracy of data processing, analysis, and interpretation, facilitating quicker discoveries and advancing understanding of complex diseases.
In August 2022, Ipsen Biopharmaceuticals, Inc., a U.S.-based pharmaceutical company that specializes in developing and commercializing medicines for three therapeutic areas, acquired Epizyme, Inc. for $247 million. Through this acquisition, Ipsen Biopharmaceuticals, Inc. aims to enhance its oncology portfolio, broaden its pipeline with innovative treatments, and strengthen its market position in cancer care. Epizyme, Inc., also a U.S.-based commercial company, focuses on creating innovative therapies based on epigenetics.
Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc
North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the global epigenetics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the epigenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
The epigenetics market includes revenues earned by entities methylation, acetylation, phosphorylation, ubiquitylation, and sumolyation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Epigenetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on epigenetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for epigenetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The epigenetics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Reagents; Enzymes; Instruments; Kits
- 2) By Technology: DNA Methylation; Histone Methylation; Histone Acetylation; Large Noncoding RNA; MicroRNA Modification; Chromatin Structures
- 3) By Application: Oncology; Metabolic Diseases; Developmental Biology; Immunology; Cardiovascular Diseases; Other Applications
- 4) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Other End Users
- Subsegments:
- 1) By Reagents: DNA Methylation Reagents; Histone Modification Reagents; RNA Modifications Reagents; Enzymes
- 2) By Enzymes: DNA Methyltransferases; Histone Acetyltransferases; Histone Deacetylases; Other Epigenetic Enzymes
- 3) By Instruments: Sequencers; PCR Machines; Microarray Platforms; Mass Spectrometers
- 4) By Kits: DNA Methylation Kits; Chromatin Immunoprecipitation (ChIP) Kits; RNA-Seq Kits; Bisulfite Conversion Kits
- Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific; Merck Millipore; Active Motif; Abcam PLC
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Epigenetics Market Characteristics
3. Epigenetics Market Trends And Strategies
4. Epigenetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Epigenetics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Epigenetics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Epigenetics Market Growth Rate Analysis
- 5.4. Global Epigenetics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Epigenetics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Epigenetics Total Addressable Market (TAM)
6. Epigenetics Market Segmentation
- 6.1. Global Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Reagents
- Enzymes
- Instruments
- Kits
- 6.2. Global Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Methylation
- Histone Methylation
- Histone Acetylation
- Large Noncoding RNA
- MicroRNA Modification
- Chromatin Structures
- 6.3. Global Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Metabolic Diseases
- Developmental Biology
- Immunology
- Cardiovascular Diseases
- Other Applications
- 6.4. Global Epigenetics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Other End Users
- 6.5. Global Epigenetics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Methylation Reagents
- Histone Modification Reagents
- RNA Modifications Reagents
- Enzymes
- 6.6. Global Epigenetics Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Methyltransferases
- Histone Acetyltransferases
- Histone Deacetylases
- Other Epigenetic Enzymes
- 6.7. Global Epigenetics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sequencers
- PCR Machines
- Microarray Platforms
- Mass Spectrometers
- 6.8. Global Epigenetics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Methylation Kits
- Chromatin Immunoprecipitation (ChIP) Kits
- RNA-Seq Kits
- Bisulfite Conversion Kits
7. Epigenetics Market Regional And Country Analysis
- 7.1. Global Epigenetics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Epigenetics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Epigenetics Market
- 8.1. Asia-Pacific Epigenetics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Epigenetics Market
- 9.1. China Epigenetics Market Overview
- 9.2. China Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Epigenetics Market
- 10.1. India Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Epigenetics Market
- 11.1. Japan Epigenetics Market Overview
- 11.2. Japan Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Epigenetics Market
- 12.1. Australia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Epigenetics Market
- 13.1. Indonesia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Epigenetics Market
- 14.1. South Korea Epigenetics Market Overview
- 14.2. South Korea Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Epigenetics Market
- 15.1. Western Europe Epigenetics Market Overview
- 15.2. Western Europe Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Epigenetics Market
- 16.1. UK Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Epigenetics Market
- 17.1. Germany Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Epigenetics Market
- 18.1. France Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Epigenetics Market
- 19.1. Italy Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Epigenetics Market
- 20.1. Spain Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Epigenetics Market
- 21.1. Eastern Europe Epigenetics Market Overview
- 21.2. Eastern Europe Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Epigenetics Market
- 22.1. Russia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Epigenetics Market
- 23.1. North America Epigenetics Market Overview
- 23.2. North America Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Epigenetics Market
- 24.1. USA Epigenetics Market Overview
- 24.2. USA Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Epigenetics Market
- 25.1. Canada Epigenetics Market Overview
- 25.2. Canada Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Epigenetics Market
- 26.1. South America Epigenetics Market Overview
- 26.2. South America Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Epigenetics Market
- 27.1. Brazil Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Epigenetics Market
- 28.1. Middle East Epigenetics Market Overview
- 28.2. Middle East Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Epigenetics Market
- 29.1. Africa Epigenetics Market Overview
- 29.2. Africa Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Epigenetics Market Competitive Landscape And Company Profiles
- 30.1. Epigenetics Market Competitive Landscape
- 30.2. Epigenetics Market Company Profiles
- 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck Millipore Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Active Motif Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abcam PLC Overview, Products and Services, Strategy and Financial Analysis
31. Epigenetics Market Other Major And Innovative Companies
- 31.1. Qiagen NV
- 31.2. Diagenode SA
- 31.3. CellCentric Ltd.
- 31.4. Chroma Medicine Inc.
- 31.5. Constellation Pharmaceuticals Inc.
- 31.6. Domainex Ltd.
- 31.7. Eisai Co. Ltd.
- 31.8. Epigen Biosciences Inc.
- 31.9. EpigenDx Inc.
- 31.10. Epigenomics AG
- 31.11. Epizyme Inc.
- 31.12. Gilead Sciences Inc.
- 31.13. GlaxoSmithKline plc
- 31.14. Janssen Pharmaceuticals Inc.
- 31.15. Locus Biosciences Inc.
32. Global Epigenetics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Epigenetics Market
34. Recent Developments In The Epigenetics Market
35. Epigenetics Market High Potential Countries, Segments and Strategies
- 35.1 Epigenetics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Epigenetics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Epigenetics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
